Obicetrapib 10 mg: clinical trials recruiting now

Fewer than 3 recruiting trials found.

Phase breakdown

Conditions being studied

Recruiting trials involving Obicetrapib 10 mg

• A Study to Evaluate the Effect of Obicetrapib/Ezetimibe 10 mg Fixed-Dose Combination or Obicetrapib 10 mg Daily on Top of Guideline-Recommended Lipid-Lowering Therapy in Participants With Type 2 Diabetes and/or Metabolic Syndrome
  NCT07219602 · Phase: Phase 3 · Ages: 18 Years and older · Sex: All (male and female) · 20 locations

Common questions

How many recruiting trials involve Obicetrapib 10 mg?

1 recruiting trial across 4 conditions.

Is this list of trials complete?

No. For the full record, search ClinicalTrials.gov.